URGENT CALL TO ACTION:

Sign the Petition to Keep Kratom Legal!

Dear Kratom Warriors:

First, let me say thank you for your support in the fight to protect kratom.  The army of kratom supporters who have emerged in every corner of our country, have become the talk of Capitol Hill. 

They know who we are.  We are an active community and one that doesn't back down from a fight.  

We just need to ask one more favor of you today...

As you know, the Ohio Board of Pharmacy is considering recommending a ban on kratom.  We have a short window to send our clear, science-based message to the members of this Board. 

Please take a minute and CO-SIGN THE PETITION that we will be sending to the Ohio Board of Pharmacy requesting they rescind their resolution on the proposed classification of kratom as a Schedule I controlled substance.

READ THE FULL PETITION HERE. 

It's absolutely critical that everyone across the United States signs this petition.  

We are now witness to the new strategy by FDA Commissioner Scott Gottlieb in his relentless quest to criminalize kratom.  He knows that he's losing the battle trying to convince the DEA and NIDA to believe his misinformation on kratom, so now he's targeting the states and their Boards of Pharmacy.  

If states are successful in designating kratom as a Schedule I substance, it instantly makes everyone who consumes kratom to manage their health and well-being a criminal.  

Make no mistake, if Ohio is successful in criminalizing kratom, other states will quickly follow.  

We are at a crossroads in the fight to protect kratom and we can't afford to lose this battle. 

Remember the old saying, "As Ohio goes, so does the nation."  We need to show FDA Commissioner Scott Gottlieb that he will not win in his new strategy to criminalize kratom - we will stand up and fight back!

Please sign the petition today. 

Sincerely,

Dave Herman

Chairman

American Kratom Association

American Kratom Association

5501 Merchants View Square #202

Haymarket, VA 20169

Follow Us

Having trouble viewing this email? View it in your web browser

Manage Subscription